Yasuhide Tei

Urinary interleukin-2 may predict clinical outcome of intravesical bacillus Calmette-Gu�rin immunotherapy for carcinoma in situ of the bladder

Etsuya Watanabe, Hideyasu Matsuyama, Kenji Matsuda et al. · Cancer Immunology Immunotherapy · 2003 · 89 citations · Full text

Medicine, Immunology, Urology +15

Prognostic value of pre-treatment risk stratification and post-treatment neutrophil/lymphocyte ratio change for pembrolizumab in patients with advanced urothelial carcinoma

Yoshiaki Yamamoto, Junji Yatsuda, Mototsugu Shimokawa et al. · International Journal of Clinical Oncology · 2020 · 41 citations

Medicine, Oncology, Pharmacotherapy +10

Use of preoperative performance status and hemoglobin concentration to predict overall survival for patients aged ≥75 years after radical cystectomy for treatment of bladder cancer

Hideyasu Matsuyama, Yoriaki Kamiryo, Shigeaki Hayashida et al. · International Journal of Clinical Oncology · 2015 · 33 citations

Medicine, Surgery, Urology +11

Granulocyte Colony-stimulating Factor may Promote Proliferation of Human Bladder Cancer Cells Mediated by Basic Fibroblast Growth Factor

Chietaka Ohmi, Hideyasu Matsuyama, Yasuhide Tei et al. · Scandinavian Journal of Urology and Nephrology · 2003 · 12 citations

Medicine, Cell Biology, Oncology +17

Identification of curable high-risk prostate cancer using radical prostatectomy alone: who are the good candidates for undergoing radical prostatectomy among patients with high-risk prostate cancer?

Kazuhiro Nagao, Hideyasu Matsuyama, Hiroaki Matsumoto et al. · International Journal of Clinical Oncology · 2018 · 10 citations · Full text

Medicine, Oncology, Urology +14